Systemic lupus erythematosus and Lupus endocarditis

Summary:

Lupus endocarditis is found among people with Systemic lupus erythematosus, especially for people who are female, 40-49 old.

The study analyzes which people have Lupus endocarditis with Systemic lupus erythematosus. It is created by eHealthMe based on reports of 30 people who have Systemic lupus erythematosus from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,089 drugs and 1,642 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.

What is Lupus endocarditis?

Lupus endocarditis (a chronic inflammatory autoimmune disorder that may affect heart) is found to be associated with 10 drugs and 15 conditions by eHealthMe. Check the latest studies of Lupus endocarditis.



On Jul, 19, 2026

30 people who have Systemic Lupus Erythematosus and Lupus Endocarditis are studied.

Would you have Lupus endocarditis when you have Systemic lupus erythematosus?

Gender of people who have Systemic Lupus Erythematosus and experienced Lupus Endocarditis *:

  • female: 95 %
  • male: 5 %

Age of people who have Systemic Lupus Erythematosus and experienced Lupus Endocarditis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 7.69 %
  • 30-39: 30.77 %
  • 40-49: 46.15 %
  • 50-59: 15.38 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 6.67%
  2. Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 2 people, 6.67%

Common drugs taken by these people *:

  1. Metformin: 11 people, 36.67%
  2. Vitamin C: 10 people, 33.33%
  3. Pantoprazole: 10 people, 33.33%
  4. Amlodipine: 10 people, 33.33%
  5. Synthroid: 10 people, 33.33%
  6. Lasix: 10 people, 33.33%
  7. Azathioprine: 7 people, 23.33%
  8. Cellcept: 7 people, 23.33%
  9. Imuran: 7 people, 23.33%
  10. Plaquenil: 7 people, 23.33%

Common symptoms for these people *:

  1. Weight Increased: 11 people, 36.67%
  2. Fluid Retention (an abnormal accumulation of fluid in the blood): 11 people, 36.67%
  3. Drug Hypersensitivity: 11 people, 36.67%
  4. Lupus Vasculitis (a chronic inflammatory autoimmune disorder that may affect blood vessels): 10 people, 33.33%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 30.00%
  6. Sle Arthritis (an autoimmune disease that causes your immune system to attack your body's own joints): 6 people, 20.00%
  7. Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 5 people, 16.67%
  8. Symptom Masked: 2 people, 6.67%
  9. Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 2 people, 6.67%
  10. Systemic Lupus Erythematosus Rash (an autoimmune disease, which means the body's immune system mistakenly attacks healthy tissue and causes the rashes): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lupus endocarditis?

- Check whether Lupus endocarditis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Lupus endocarditis:

All the conditions that are associated with Lupus endocarditis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lupus endocarditis and Systemic lupus erythematosus, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: